News from Pritzker Levine LLP, Robbins Geller Rudman & Dowd LLP, Sharp Law, LLP, Burns Charest LLP and Keller Rohrback L.L.P.
A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Making a selection with these dropdown will cause content on this page to change. News listings will update as each option is selected.
Mar 18, 2022, 16:00 ET
Pritzker Levine LLP, Robbins Geller Rudman & Dowd LLP, Sharp Law, LLP, Burns Charest LLP and Keller Rohrback L.L.P., Announce a Class Action Settlement with Mylan for Purchasers of EpiPen®, EpiPen Jr® and/or their Authorized Generics
EpiPen® ("EpiPen") Auto-Injector Class Action Settlement with Mylan for $264 Million In re EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING, SALES...
Mar 18, 2022, 16:00 ET
Pritzker Levine LLP, Robbins Geller Rudman & Dowd LLP, Sharp Law, LLP, Burns Charest LLP and Keller Rohrback L.L.P., Announce a Class Action Settlement with Mylan for Purchasers of EpiPen®, EpiPen Jr® and/or their Authorized Generics
EpiPen® ("EpiPen") Auto-Injector Class Action Settlement with Mylan for $264 Million In re EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING, SALES...
Oct 25, 2021, 10:00 ET
Pritzker Levine LLP, Robbins Geller Rudman & Dowd LLP, Sharp Law, LLP, Burns Charest LLP and Keller Rohrback L.L.P., reminder of the November 12, 2021, deadline to submit a claim for compensation from a $345 Million Class Action Settlement with Defendant Pfizer Inc. for Purchasers of EpiPen, EpiPen Jr. and/or their Authorized Generics
The November 12, 2021, deadline to submit a claim to receive compensation is approaching. To submit a claim, please visit...
